Dynamics of <i>Helicobacter pylori</i> infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial
Robertino M. Mera(Center for HIV and Hepatogastroenterology), M. Blanca Piazuelo(Vanderbilt University Medical Center), Douglas R. Morgan(University of Alabama at Birmingham), Luis Eduardo Bravo(Universidad del Valle), Keith T. Wilson(VA Tennessee Valley Healthcare System), María Clara Yépez(University of Nariño), Richard M. Peek(Vanderbilt University Medical Center), José Luis Realpe(University of Nariño), Barbara Schneider(Altonaer Kinderkrankenhaus), Juan Carlos Bravo(Universidad del Valle), Judith Romero–Gallo(Vanderbilt University Medical Center), Alberto G. Delgado(Vanderbilt University Medical Center), Pelayo Correa(Center for HIV and Hepatogastroenterology), M. Constanza Camargo(National Institutes of Health)
Cited by 182
Related Papers
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Helicobacter pylori and gastrointestinal tract adenocarcinomas
|Nature reviews. Cancer|2002|1.8k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
|Cancer Cell|2018|718